PM360 2018 Innovative Product ReferralMAPML from Saatchi & Saatchi Wellness

ReferralMAPML

Saatchi & Saatchi Wellness

Kevin Troyanos, SVP, Analytics & Data Science
kevin.troyanos@saatchiwellness.com

Saatchi & Saatchi Wellness heard a common question from clients: How can we better identify what types of providers play a role in diagnosing and treating a particular condition so that we can communicate the value of our products to the right physicians in the right context?

So, in 2018, the company developed its newest data science framework, ReferralMAPML, which seeks to help clients distinguish and identify diagnosis, referral, and treatment patterns of physicians at scale through techniques rooted in unsupervised learning algorithms, network analytics, and graph theory. Together, these domains provide a theoretical structure for understanding interdependencies between HCPs and the events that connect them, i.e., diagnoses and procedures pertaining to a given patient. Notably, ReferralMAPML can also be combined with Saatchi & Saatchi Wellness’ flagship offering TrueTargetML, which makes it possible to build highly accurate models that are able to predict healthcare providers’ likelihood of being a referring, diagnosing, or treating physician.

By using ReferralMAPML, companies can classify providers according to their role as a referring physician who issues or verifies a diagnosis, or a treating physician who ultimately writes a prescription for and/or administers the patient’s ultimate choice of therapy. The ReferralMAPML framework can also analyze the referral network at scale, and examine how individuals fit into specific “layers” of referral activity, i.e., what are the key drivers that distinguish healthcare providers who tend to refer directly to treating physicians from those whose pattern of referrals typically come earlier in the patient’s journey? By marrying this information with the many other dimensions that ReferralMAPML can examine in detail—including specialty, geography, and the network dynamics of competitors—marketers can understand how providers interact with patients in a given therapeutic category and serve both of their needs with more relevant, timelier communications.

Ads

You May Also Like

ELITE 2019 Digital Crusader Don Feiler of Calcium

Don Feiler Partner, Chief Digital Officer Calcium At the Forefront of Digital Innovation For ...

ELITE 2018 Transformational Leader Jay Newman of Spark Therapeutics

Jay Newman Head of U.S. Market & Patient Access Spark Therapeutics Creating a Payer ...

PM360 2018 Trailblazer Awards Rare Diseases Brand Champion Bonnie Ben-Shmuel

Bonnie Ben-Shmuel, Director, Planning and Innovation, Pfizer Rare Disease In her role at Pfizer, ...